Pegasys-AU (Peginterferon alfa-2a PFS) 180 mcg/0.5mL

Pegasys-AU (Peginterferon alfa-2a) 180 mcg/0.5mL is a prescription medication used in certain viral infections. Administered via prefilled syringe, it supports immune response modulation. Always consult a healthcare provider before use.

Strength

180 mcg/0.5mL

Manufacturer / TM Owner

Eco Therapeutics Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pegasys-AU (Peginterferon alfa-2a) 180 mcg/0.5mL is prescribed for chronic hepatitis B and C infections. It may also be used in combination therapies for viral suppression. Patients often ask, 'what is Peginterferon alfa-2a used for' to understand its role in treatment plans.

Side Effects

Pegasys-AU (Peginterferon alfa-2a) 180 mcg/0.5mL may cause flu-like symptoms such as fatigue, fever, or muscle aches shortly after administration. Some users report mild headache or injection site reactions. These effects are generally temporary and vary by individual.

Precautions & Warnings

Store Pegasys-AU (Peginterferon alfa-2a) 180 mcg/0.5mL in a refrigerator and protect from light. Avoid freezing or shaking the prefilled syringe. Discard any unused medication after the expiration date. Always follow handling instructions provided by your pharmacist.

Avoid Interactions

Pegasys-AU (Peginterferon alfa-2a) 180 mcg/0.5mL may interact with medications that affect the immune system or bone marrow. Alcohol and certain herbal supplements can influence its effects. Discuss all current medications with your doctor to minimize risks.

Frequently Asked Questions

Pegasys-AU is given as an injection under the skin, typically once weekly. Follow your healthcare provider's instructions for proper use.

Contact your doctor if you miss a dose. Do not take a double dose to make up for the missed one unless advised.

Pegasys-AU requires a prescription and is available through licensed pharmacies. Verify the pharmacy's credentials before purchasing.

Pegasys-AU may not be recommended during pregnancy. Discuss risks and benefits with your healthcare provider.

Common side effects include fatigue, fever, and injection site reactions. Most are mild and temporary.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.